Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Advanced prostate cancer cases are rising worldwide as fewer men undergo routine PSA screening and early symptoms go ...

The UCLA trial is currently enrolling patients.

PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...

Many clinicians who treat men with prostate cancer may be unfamiliar with the term "treatment-emergent small-cell neuroendocrine prostate cancer" (t-SCNC). That's because it has been considered a rare ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide treatment decisions for patients with advanced prostate cancer. The guide, ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

SGLT2 inhibitors linked to lower hormone therapy failure in prostate cancer. Learn more about their potential role in improving treatment outcomes.

New report shows growing use of medications, such as chemotherapy, immunotherapy, and hormone therapy, given before surgery ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...